MBIA Inc.

MBI

CIK 0000814585 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$28M
↑+115.4% +$15Mvs FY2024 (Q4)
Operating Income
$28M
↑+115.4% +$15Mvs FY2024 (Q4)
Gross Profit
$28M
↑+115.4% +$15Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
17/100
  • Profitability
    0Insufficient data
  • Liquidity
    0Insufficient data
  • Leverage
    0D/E 2.66 (under 0.5 = conservative)
  • Efficiency
    0Asset Turnover 0.04x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +115.4% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project MBI's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$13.27
Total enterprise IV
$654M
Diluted shares
0.05B
Terminal PV
$474M (72% of total)
Year-5 FCF
$56M
YearProjected FCFDiscounted PV
+1$41M$37M
+2$44M$37M
+3$48M$36M
+4$52M$35M
+5$56M$35M
Terminal$763M$474M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
investment in PP&E
Dividends paid (TTM)
cash returned to holders
Stock buybacks (TTM)
$7M
share count reduction
Stock-based comp (TTM)
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$2.01B
everything owned
Total liabilities
$4.24B
everything owed
Stockholders' equity
$-2.24B
shareholder claim
Net debt
$2.08B
LT debt minus cash

Recent performance · 67 quarters

Revenue↑+115.4% +$15M
$28M
Net Income↑+85.7% +$48M
$-8M
Free Cash Flow
$90M

Drill down